Moximed launches new trial comparing implantable knee device to non-surgical OA treatments
3 Articles
3 Articles
Moximed announces treatment of first subject in trial of knee system
Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA knee system.The post Moximed announces treatment of first subject in trial of knee system appeared first on Medical Device Network.
First Patients Treated in a New Randomized Controlled Trial Evaluating the MISHA® Knee System vs. Non-Surgical Treatment for Knee Osteoarthritis – Ortho Spine News
Distinguished orthopaedic institutions across the United States continue to generate evidence regarding the therapeutic use of surgical unloading for knee osteoarthritis. FREMONT, Calif., May 29, 2025 -(BUSINESS WIRE)- Moximed, an innovative medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the first patients have been treated in a new randomized controlled trial (RCT) ev
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage